Home Cart Sign in  
Chemical Structure| 1222513-26-9 Chemical Structure| 1222513-26-9

Structure of CID44216842
CAS No.: 1222513-26-9

Chemical Structure| 1222513-26-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CID44216842 is a novel GPR40 receptor antagonist showing potential applications in research for treating diabetes and related metabolic diseases.

Synonyms: Cdc42-IN-1

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of CID44216842

CAS No. :1222513-26-9
Formula : C22H20BrN3O3S
M.W : 486.38
SMILES Code : O=S(C1=CC=C(C=C1)N2N=C(CC2C3=CC=C(C=C3)Br)C4=CC=CC(OC)=C4)(N)=O
Synonyms :
Cdc42-IN-1
MDL No. :MFCD28009507
InChI Key :LPUYDLXQQMWRLR-UHFFFAOYSA-N
Pubchem ID :44216842

Safety of CID44216842

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P313-P337+P313-P362-P403+P233-P405-P501

Related Pathways of CID44216842

GPCR

Isoform Comparison

Biological Activity

Description
CID44216842 (Cdc42-IN-1) is a highly effective inhibitor that selectively targets Cdc42 by binding to its guanine nucleotide-binding site. In GTP binding assays, the EC50 values for Cdc42 WT and the Cdc42Q61L mutant are 1.0 μM and 1.2 μM, respectively. Similarly, in GDP binding assays, the EC50 values for Cdc42 WT and the Cdc42Q61L mutant are 0.3 μM and 0.5 μM, respectively. This compound serves as a valuable molecular probe [1].

In Vitro:

Cell Line
Concentration Treated Time Description References
U937 FPRΔST cells 10 µM 24 h Assessment of cytotoxicity, no significant toxicity observed J Biol Chem. 2013 Mar 22;288(12):8531-8543
Swiss 3T3 cells 10 µM 1 h Inhibition of Cdc42-related filopodia formation J Biol Chem. 2013 Mar 22;288(12):8531-8543
OVCA429 and SKOV3ip cells 0.1 to 10 µM 95 h Assessment of cytotoxicity, no significant toxicity observed J Biol Chem. 2013 Mar 22;288(12):8531-8543
RCH-ACV cells 20 μM 60 h To evaluate the effect of CID44216842 on the proliferation and apoptosis of RCH-ACV cells. The results showed that CID44216842 significantly inhibited the proliferation of RCH-ACV cells and increased apoptosis. Haematologica. 2024 Jul 1;109(7):2092-2110

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Zebrafish Tg(hsp70:E2A-PBX1-EGFP) transgenic zebrafish Soaking 20 μM Treatment started at 4 dpf and lasted until 6 dpf To evaluate the effect of CID44216842 on hE2A-PBX1-induced myeloid expansion in zebrafish. The results showed that CID44216842 significantly reduced the number of SB+ granulocytes and alleviated myeloid expansion. Haematologica. 2024 Jul 1;109(7):2092-2110

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.06mL

0.41mL

0.21mL

10.28mL

2.06mL

1.03mL

20.56mL

4.11mL

2.06mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories